2011-2013年我院治疗心脑血管疾病中成药的用药合理性

Rational Use of Traditional Chinese Medicines for the Treatment of Cardiovascular and Cerebrovascular Diseases in Our Hospital in 2011-2013

目的:分析2011-2013年我院治疗心脑血管疾病的20种中成药的使用情况,为临床合理用药提供参考。方法:对我院3年来治疗心脑血管疾病的中成药用药金额、用药频度进行统计分析。结果:3年来我院治疗心脑血管疾病的中成药用药频度呈逐年递增趋势,复方丹参滴丸一直位列第1,2013年银杏酮酯滴丸和速效救心丸有明显增长,位居第2、3位。结论:2011-2013年我院治疗心脑血管疾病的20种中成药使用基本合理,临床医生应根据辨证施治原则合理用药。

Objective： To analyze the usage of 20 kinds of traditional Chinese medicines for the treatment of cardiovascular and cerebrovascular diseases in our hospital from 2011 to 2013, and to provide a reference for rational use of traditional Chinese medicines. Methods： The traditional Chinese medicines used in the three years in our hospital for cardiovascular and cerebrovaseular diseases were analyzed statistically in respect of consumption sum of medication and DDDs. Results： The DDDs of traditional Chinese medicines used for cardiovascular and cerebrovascular diseases increased year by year. Compound Danshen dripping pills ranked the first over the three years, which was followed by Ginkgo biloba extract dropping pills and Suxiaojiuxin pills. Conclusion： The application of 20 kinds of traditional Chinese medicines for the treatment of cardiovascular and cerebrovascular diseases in our hospital was generally reasonable. Clinicians should follow the principle of syndrome differentiation and use medicines reasonably.